Covered recipient · General Payments record
DANA C THORDSEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$711.93
- Reported across 46 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $153.35 | 9 |
| Education | $64.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $79.40 | 2 |
| Amgen Inc. | $54.04 | 3 |
| Lilly USA, LLC | $37.87 | 2 |
| Acerta Pharma LLC | $17.17 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.06 | 1 |
| Mylan Specialty L.P. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.24 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116177716 | CMS |
| Amgen Inc. | $15.74 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116177720 | CMS |
| Amgen Inc. | $20.06 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116177724 | CMS |
| Astellas Pharma US Inc | $14.41 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139473714 | CMS |
| Astellas Pharma US Inc | $64.99 | 02/08/2024 | Education | Undisputed | 01/23/2026 | 1139504135 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.17 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105652410 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $15.06 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118228039 | CMS |
| Lilly USA, LLC | $16.63 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135611919 | CMS |
| Lilly USA, LLC | $21.24 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135598555 | CMS |
| Mylan Specialty L.P. | $14.80 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147376074 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.